Key Findings: 
Type of Study: 
Study Result:  Inconclusive
Research Location(s): 
Year of Pub: 
Cannabinoids Studied: 
Chemotype: 
Terpenes Studied: 
Receptors Studied: 
Ligands Studied: 
DOSING DETAILS   
Study Dosing Objective:  Effective Dose
Established Protocol:  Effective dose
Route of Administration: 
Cannabinoid Ratio:  (CBD : THC)   4 : 1    
Dosage Form:  Avidekel oil contained 16% CBD and 4% THC. Each oil drop is approximately 0.05 ml, containing about 8 mg CBD and 2 mg THC. Place the oil under the tongue and roll it in their mouth until absorbed
Dosing Regimen:  Patients received either cannabis oil containing 160/40mg/ml CBD/THC or placebo
Starting Dose:  starting dose was 1 drop twice daily before meals
Titration:  gradually increased until the patient felt a satisfactory effect
Maximum Dose:  maximal allowed dose was 20 drops per administration
Treatment Duration:  eight weeks
Clinical Relevance:  CBD-rich cannabis resulted in a significant clinical and quality of life improvement in patients with Crohn's disease but without changes in inflammatory parameters or endoscopic scores.
Adverse Events:  The only symptom that was more common in the extract group was decreased memory
Additional Notes:  Pharmacokinetic Study Data, Parallel Dose Comparison
Citation: